William K. Murphy

3.6k total citations
73 papers, 2.9k citations indexed

About

William K. Murphy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, William K. Murphy has authored 73 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 31 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in William K. Murphy's work include Lung Cancer Research Studies (26 papers), Lung Cancer Treatments and Mutations (17 papers) and Neuroendocrine Tumor Research Advances (13 papers). William K. Murphy is often cited by papers focused on Lung Cancer Research Studies (26 papers), Lung Cancer Treatments and Mutations (17 papers) and Neuroendocrine Tumor Research Advances (13 papers). William K. Murphy collaborates with scholars based in United States, United Kingdom and Israel. William K. Murphy's co-authors include Frank V. Fossella, Bonnie S. Glisson, Hari M. Dhingra, Waun Ki Hong, Dong M. Shin, Manuel Valdivieso, Theera Umsawasdi, Scott M. Lippman, Gerald P. Bodey and Steven E. Benner and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

William K. Murphy

72 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William K. Murphy United States	29	2.0k	1.3k	702	509	427	73	2.9k
R. G. Hahn United States	19	1.2k 0.6×	643 0.5×	396 0.6×	310 0.6×	280 0.7×	45	1.9k
Giuseppina Catalano Italy	28	1.4k 0.7×	835 0.6×	268 0.4×	377 0.7×	213 0.5×	72	2.2k
B. J. Kennedy United States	28	732 0.4×	962 0.7×	530 0.8×	641 1.3×	226 0.5×	82	2.7k
Ralph Levitt United States	27	2.1k 1.1×	892 0.7×	670 1.0×	682 1.3×	424 1.0×	67	3.6k
Ronald G. Stoller United States	27	2.0k 1.0×	535 0.4×	920 1.3×	282 0.6×	310 0.7×	63	3.5k
Tetsu Shinkai Japan	29	2.0k 1.0×	1.8k 1.4×	782 1.1×	401 0.8×	338 0.8×	146	3.2k
Paolo Bidoli Italy	27	2.0k 1.0×	1.9k 1.5×	531 0.8×	365 0.7×	190 0.4×	127	3.1k
A Mittelman United States	26	1.3k 0.7×	642 0.5×	541 0.8×	398 0.8×	103 0.2×	104	2.6k
Don V. Jackson United States	27	1.3k 0.7×	508 0.4×	337 0.5×	219 0.4×	251 0.6×	75	2.0k
T Ishikawa Japan	13	1.5k 0.8×	590 0.5×	412 0.6×	440 0.9×	142 0.3×	34	2.3k

Countries citing papers authored by William K. Murphy

Since Specialization

Citations

This map shows the geographic impact of William K. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William K. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William K. Murphy more than expected).

Fields of papers citing papers by William K. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William K. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William K. Murphy. The network helps show where William K. Murphy may publish in the future.

Co-authorship network of co-authors of William K. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of William K. Murphy. A scholar is included among the top collaborators of William K. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William K. Murphy. William K. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Glisson, Bonnie S., et al.. (1998). Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma. Cancer. 82(2). 301–308. 11 indexed citations

Glisson, Bonnie S., Ritsuko Komaki, Jin Soo Lee, et al.. (1998). Integration of filgrastim into chemoradiation for limited small cell lung cancer: A phase I study. International Journal of Radiation Oncology*Biology*Physics. 40(2). 331–336. 6 indexed citations

Fossella, Frank V., S. M. Lippman, Dong M. Shin, et al.. (1997). Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 15(1). 310–316. 104 indexed citations

Murphy, William K., et al.. (1996). Endoscopic injection for bleeding peptic ulcer: A comparison of adrenaline alone with adrenaline plus human thrombin. Gastroenterology. 111(3). 623–628. 78 indexed citations

Pérez-Soler, Román, Bonnie S. Glisson, John Lee, et al.. (1996). Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.. Journal of Clinical Oncology. 14(10). 2785–2790. 106 indexed citations

Fossella, Frank V., Dongjun Shin, Mark Calayag, et al.. (1995). Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.. Journal of Clinical Oncology. 13(3). 645–651. 221 indexed citations

Fossella, Frank V., William K. Murphy, Scott M. Lippman, et al.. (1994). Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.. Journal of Clinical Oncology. 12(6). 1238–1244. 197 indexed citations

Hesketh, Paul J., W. Henwood Harvey, W G Harker, et al.. (1994). A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis.. Journal of Clinical Oncology. 12(3). 596–600. 115 indexed citations

Murphy, William K., Frank V. Fossella, R Winn, et al.. (1993). Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 85(5). 384–388. 373 indexed citations

10.

Beck, Thomas, Paul J. Hesketh, Stefan Madajewicz, et al.. (1992). Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting.. Journal of Clinical Oncology. 10(12). 1969–1975. 77 indexed citations

11.

Lee, J. S., H I Libshitz, Frank V. Fossella, et al.. (1992). Improved Therapeutic Index by Leucovorin of Edatrexate, Cyclophosphamide, and Cisplatin Regimen for Non-Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 84(13). 1039–1040. 12 indexed citations

12.

Warrell, Raymond P., William K. Murphy, Philip Schulman, P J O’Dwyer, & Glenn Heller. (1991). A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.. Journal of Clinical Oncology. 9(8). 1467–1475. 73 indexed citations

13.

Keating, Michael J., Jeane P. Hester, Kenneth B. McCredie, et al.. (1990). Long-Term Results of CAP Therapy in Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 2(6). 391–397. 29 indexed citations

14.

Holoye, Paul Y., Marion J. McMurtrey, C. F. Mountain, et al.. (1990). The role of adjuvant surgery in the combined modality therapy of small-cell bronchogenic carcinoma after a chemotherapy-induced partial remission.. Journal of Clinical Oncology. 8(3). 416–422. 8 indexed citations

15.

Hesketh, Paul J., William K. Murphy, Eric P. Lester, et al.. (1989). GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.. Journal of Clinical Oncology. 7(6). 700–705. 80 indexed citations

16.

Holoye, Paul Y., David Carr, Hari M. Dhingra, et al.. (1988). Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma. Investigational New Drugs. 6(3). 217–218. 5 indexed citations

17.

Umsawasdi, Theera, Manuel Valdivieso, H. Thomas Barkley, et al.. (1988). Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 14(1). 43–48. 11 indexed citations

18.

Murphy, William K., et al.. (1981). Neocarzinostatin: report of a phase II clinical trial.. PubMed. 65(7-8). 699–701. 7 indexed citations

19.

Murphy, William K., R. B. Livingston, E. A. Gehan, & Gerald P. Bodey. (1977). Sequential chemotherapy in the treatment of cancer of the head and neck. Proceedings of the American Association for Cancer Research. 18. 2 indexed citations

20.

Murphy, William K., R. B. Livingston, & Jeffrey A. Gottlieb. (1976). Phase I evaluation of anguidine. Proceedings of the American Association for Cancer Research. 17. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact